FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178476192> ?p ?o ?g. }

• W3178476192 abstract "BACKGROUND: AbobotulinumtoxinA (AboBoNT-A; Dysport®; Ipsen, Boulogne-Billancourt, France/Azzalure®; Galderma, Lausanne, Switzerland) is a botulinum neurotoxin type A approved for aesthetic use in the treatment of glabellar lines in adult patients under 65 years in Europe, the United States, and other countries. OBJECTIVE: We sought to analyze current literature on patient satisfaction with aboBoNT-A for upper facial aesthetic indications. METHODS: A systematic review of literature databases (PubMed/MEDLINE, Embase, the Cochrane Library, and Google Scholar) was performed to identify English-language publications reporting on patients with aesthetic indications (including glabellar lines and wrinkles) receiving aboBoNT-A, that assessed patient and/or physician satisfaction with treatment, with no restrictions on comparator studies. Structured data extraction was used to enable inter-study analysis. A post-hoc analysis was also performed to assess patient satisfaction by sex and age, using results from the noninterventional APPEAL study of patients' satisfaction with aboBoNT-A for treating glabellar lines. RESULTS: Overall, 22 original research papers were identified. Patient satisfaction rates for aboBoNT-A treatment were significantly higher versus placebo from two weeks to between three and five months postinjection. At two to three weeks postinjection, patient satisfaction rates were 52% and 99% across studies. In studies with later time points, patient satisfaction rates were 85 to 87 percent at 5 months and between 25 and 100 percent at 6 months post-injection. Physician satisfaction was also high (97%-100%, across three treatments). No notable differences in patient satisfaction by sex or age were observed in the APPEAL study. CONCLUSION: High rates of patient satisfaction have been achieved with aboBoNT-A treatment for upper facial aesthetic indications. Despite the current recommended interval of ≥12 weeks, satisfaction with the aesthetic results of aboBoNT-A therapy is still evident up to 6 months post-injection in some patients." @default.
• W3178476192 created "2021-07-19" @default.
• W3178476192 creator A5006663264 @default.
• W3178476192 creator A5007181593 @default.
• W3178476192 creator A5008477623 @default.
• W3178476192 creator A5044388839 @default.
• W3178476192 creator A5062317011 @default.
• W3178476192 creator A5065115759 @default.
• W3178476192 creator A5076012144 @default.
• W3178476192 creator A5083656193 @default.
• W3178476192 creator A5090580870 @default.
• W3178476192 date "2021-02-01" @default.
• W3178476192 modified "2023-09-26" @default.
• W3178476192 title "Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study." @default.
• W3178476192 cites W1965325494 @default.
• W3178476192 cites W1968315125 @default.
• W3178476192 cites W1977644637 @default.
• W3178476192 cites W1979821848 @default.
• W3178476192 cites W1995052996 @default.
• W3178476192 cites W1997886322 @default.
• W3178476192 cites W2005681491 @default.
• W3178476192 cites W2017044005 @default.
• W3178476192 cites W2029595472 @default.
• W3178476192 cites W2030342052 @default.
• W3178476192 cites W2032037900 @default.
• W3178476192 cites W2049307131 @default.
• W3178476192 cites W2083202899 @default.
• W3178476192 cites W2098923148 @default.
• W3178476192 cites W2106576433 @default.
• W3178476192 cites W2110507487 @default.
• W3178476192 cites W2128294436 @default.
• W3178476192 cites W2139061180 @default.
• W3178476192 cites W2150011772 @default.
• W3178476192 cites W2156098321 @default.
• W3178476192 cites W2404622801 @default.
• W3178476192 cites W2417535033 @default.
• W3178476192 cites W2466084791 @default.
• W3178476192 cites W2559791547 @default.
• W3178476192 cites W2605281030 @default.
• W3178476192 cites W2777145355 @default.
• W3178476192 cites W2791216237 @default.
• W3178476192 cites W2887524746 @default.
• W3178476192 cites W2891973448 @default.
• W3178476192 cites W2893442805 @default.
• W3178476192 cites W2905303601 @default.
• W3178476192 cites W3011275864 @default.
• W3178476192 cites W3122241856 @default.
• W3178476192 cites W65584209 @default.
• W3178476192 cites W2051404057 @default.
• W3178476192 cites W2933496167 @default.
• W3178476192 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8211347" @default.
• W3178476192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34221231" @default.
• W3178476192 hasPublicationYear "2021" @default.
• W3178476192 type Work @default.
• W3178476192 sameAs 3178476192 @default.
• W3178476192 citedByCount "1" @default.
• W3178476192 countsByYear W31784761922022 @default.
• W3178476192 crossrefType "journal-article" @default.
• W3178476192 hasAuthorship W3178476192A5006663264 @default.
• W3178476192 hasAuthorship W3178476192A5007181593 @default.
• W3178476192 hasAuthorship W3178476192A5008477623 @default.
• W3178476192 hasAuthorship W3178476192A5044388839 @default.
• W3178476192 hasAuthorship W3178476192A5062317011 @default.
• W3178476192 hasAuthorship W3178476192A5065115759 @default.
• W3178476192 hasAuthorship W3178476192A5076012144 @default.
• W3178476192 hasAuthorship W3178476192A5083656193 @default.
• W3178476192 hasAuthorship W3178476192A5090580870 @default.
• W3178476192 hasConcept C126322002 @default.
• W3178476192 hasConcept C141071460 @default.
• W3178476192 hasConcept C142724271 @default.
• W3178476192 hasConcept C17744445 @default.
• W3178476192 hasConcept C1862650 @default.
• W3178476192 hasConcept C199539241 @default.
• W3178476192 hasConcept C204787440 @default.
• W3178476192 hasConcept C27081682 @default.
• W3178476192 hasConcept C2775944032 @default.
• W3178476192 hasConcept C2776478404 @default.
• W3178476192 hasConcept C2778449503 @default.
• W3178476192 hasConcept C2779473830 @default.
• W3178476192 hasConcept C2992886853 @default.
• W3178476192 hasConcept C512399662 @default.
• W3178476192 hasConcept C67761136 @default.
• W3178476192 hasConcept C71924100 @default.
• W3178476192 hasConcept C95190672 @default.
• W3178476192 hasConceptScore W3178476192C126322002 @default.
• W3178476192 hasConceptScore W3178476192C141071460 @default.
• W3178476192 hasConceptScore W3178476192C142724271 @default.
• W3178476192 hasConceptScore W3178476192C17744445 @default.
• W3178476192 hasConceptScore W3178476192C1862650 @default.
• W3178476192 hasConceptScore W3178476192C199539241 @default.
• W3178476192 hasConceptScore W3178476192C204787440 @default.
• W3178476192 hasConceptScore W3178476192C27081682 @default.
• W3178476192 hasConceptScore W3178476192C2775944032 @default.
• W3178476192 hasConceptScore W3178476192C2776478404 @default.
• W3178476192 hasConceptScore W3178476192C2778449503 @default.
• W3178476192 hasConceptScore W3178476192C2779473830 @default.
• W3178476192 hasConceptScore W3178476192C2992886853 @default.
• W3178476192 hasConceptScore W3178476192C512399662 @default.
• W3178476192 hasConceptScore W3178476192C67761136 @default.
• W3178476192 hasConceptScore W3178476192C71924100 @default.

• next